Maryland has one of the highest opioid overdose death rates in the country, and Medicaid is the single largest payer for opioid use disorder treatment in the state. If you’re trying to figure out what opioid treatment is covered by Medicaid before picking up the phone, this article gives you the full picture, from specific medications and therapy to residential care and what happens if you don’t have coverage yet.
What Maryland Medicaid Covers for Opioid Use Disorder Treatment
According to the Maryland Department of Health, opioid-related overdose deaths claimed more than 2,800 lives in Maryland in 2022 alone. Behind each of those statistics is a person who either couldn’t access treatment or didn’t know it was available to them. Coverage details aren’t bureaucratic fine print. They’re the difference between starting treatment this week and spending another month trying to figure out if you can afford it.
This article is written for adults in Maryland who are living with opioid use disorder, whether you’re dependent on heroin, fentanyl, or prescription painkillers, and for family members trying to help someone start care. It answers what Maryland Medicaid actually covers, what it doesn’t, and what to do next.
How Many People With OUD Rely on Medicaid in Maryland
A 2023 KFF analysis found that Medicaid covers roughly 4 in 10 adults with opioid use disorder nationwide, making it the dominant payer for OUD treatment by a wide margin. In Maryland, that share is higher than the national average, driven in large part by the state’s Medicaid expansion under the Affordable Care Act. SAMHSA data consistently shows that low-income adults with substance use disorders are disproportionately enrolled in Medicaid, not private insurance.
The plain-language takeaway: if you’re uninsured or working a job without benefits in Maryland, Medicaid is your most direct path to covered treatment. You don’t have to navigate a commercial insurance network or pay out of pocket while waiting for coverage to start. Medicaid was built, in part, for exactly this situation.
What Opioid Use Disorder Treatment Medicaid Actually Covers
Maryland Medicaid covers a defined set of OUD services across multiple levels of care. The following sections map each one clearly.
Medication-Assisted Treatment (MAT)
The three FDA-approved medications for opioid use disorder are buprenorphine, methadone, and naltrexone. Maryland Medicaid covers all three. A 2021 study published in the New England Journal of Medicine, drawing on data from more than 17,000 patients, found that buprenorphine and methadone reduced opioid overdose mortality by 38% and 59%, respectively, compared to no medication treatment. These are not marginal effects. They are among the largest mortality reductions documented in addiction medicine.
You don’t need to walk in knowing which medication is right for you. That decision belongs to a prescriber who will assess your history, current use pattern, and any co-occurring health conditions. Your job is to show up. The clinical team determines the fit. If you want to understand how to locate a provider who bills Medicaid for buprenorphine specifically, that’s a good place to start before your first call.
Counseling and Behavioral Health Services
Maryland Medicaid covers individual counseling, group therapy, cognitive behavioral therapy, and treatment for co-occurring mental health conditions like depression, anxiety, and PTSD. A 2020 study in JAMA Psychiatry, following 1,383 patients in opioid treatment programs over 18 months, found that patients who received both medication and counseling had significantly higher rates of sustained abstinence than those who received medication alone.
When you call a provider, ask one specific question: are behavioral health services billed separately or bundled into my treatment? The answer determines whether you’ll see a separate cost-sharing requirement for therapy appointments. Some programs include counseling as part of an integrated package. Others bill it under a separate behavioral health benefit. Knowing upfront prevents surprises.
Inpatient and Residential Treatment
Maryland Medicaid covers inpatient detox and residential rehabilitation services, though with some conditions worth understanding. Federal Medicaid law historically excluded payments to Institutions for Mental Disease (IMDs), a rule that limited Medicaid reimbursement for residential facilities with more than 16 beds. Maryland has obtained waiver authority that partially addresses this restriction, expanding access to residential SUD treatment for Medicaid enrollees.
A Georgetown Center for Children and Families analysis of state Medicaid SUD benefits confirmed that Maryland is among the states that have used waiver flexibility to extend residential coverage. The practical reality: residential treatment almost always requires prior authorization. Knowing this before you or your family member needs an inpatient bed means you can ask the provider to initiate that authorization process immediately, rather than discovering the requirement mid-crisis.
Outpatient and Intensive Outpatient Programs (IOP)
Standard outpatient treatment typically means one to three hours of services per week, while intensive outpatient programs run nine hours or more per week, usually across three days. Maryland Medicaid covers both. A 2019 study in the Journal of Substance Abuse Treatment, analyzing outcomes for 642 patients with opioid use disorder, found that IOP completion rates were strongly associated with 12-month abstinence, particularly when combined with medication.
IOP is often the right entry point for people who don’t need medically supervised detox but whose lives and schedules can support a structured program. If you’re uncertain which level of care fits your situation, the fastest way to find out is an outpatient assessment. Most Medicaid-accepting providers can complete that assessment at your first appointment and place you at the appropriate level of care the same week.
Opioid Treatment Programs (OTPs) and Office-Based Treatment
Federally certified Opioid Treatment Programs (OTPs), sometimes called methadone clinics, dispense methadone daily under supervised conditions. Office-based opioid treatment (OBOT) refers to providers, often primary care physicians or addiction medicine specialists, who prescribe buprenorphine in a standard clinical setting. Maryland Medicaid reimburses both models.
SAMHSA data from 2022 showed that OTP enrollment has grown steadily in Maryland, with more than 18,000 patients receiving methadone through certified programs. Methadone requires daily clinic visits, at least initially. Buprenorphine can be prescribed and refilled through a regular office visit, which makes it more compatible with work schedules and family obligations. Neither is better in the abstract. The right choice depends on your history and what you’ll actually stick with.
What Maryland Medicaid Does Not Cover (and the Workarounds)
Maryland Medicaid does not cover experimental treatments, services from non-certified providers, or programs that fall outside the defined benefit structure. A 2022 MACPAC report on Medicaid SUD coverage found that service limits, such as caps on the number of covered counseling sessions per year, remain a gap in some state plans, including provisions affecting adults in certain managed care arrangements.
Prior authorization denials are the most common access barrier. If a service is denied, request a written explanation of benefits immediately. The denial notice will specify the reason, and that reason determines whether an appeal is worth filing. Denials based on medical necessity are often overturned when a provider submits clinical documentation. Denials based on benefit limits are harder to appeal but worth challenging if the clinical record supports it. Before accepting any denial as final, confirm your specific benefits by verifying your coverage directly rather than relying on a provider’s assumption.
How Maryland’s Medicaid Expansion Changed OUD Access
Maryland expanded Medicaid under the ACA in 2014, making adults with incomes up to 138% of the federal poverty level eligible. For a single adult, that threshold was approximately $20,120 per year in 2024. KFF data shows that Medicaid expansion states saw significantly larger increases in OUD treatment access than non-expansion states, with coverage rates for low-income adults with substance use disorders rising sharply after 2014.
For the Georgetown Center for Children and Families, which has tracked expansion’s effects on behavioral health access, Maryland’s Medicaid program has consistently ranked among the more comprehensive state plans for SUD coverage. The direct implication: if your income is low or inconsistent, including gig work, part-time employment, or periods of unemployment, you likely qualify. If you’re unsure, call 211 Maryland or visit Maryland Health Connection online. An eligibility determination takes under 15 minutes.
How MAT Reduces Overdose Deaths: The Evidence Base
The 2021 New England Journal of Medicine study referenced earlier followed patients released from incarceration, a population with extremely high overdose risk, and found that extended-release naltrexone reduced overdose events by 52% in the 24 weeks following release compared to those receiving no medication. A separate NIDA-funded study published in 2020, analyzing claims data from more than 40,000 Medicaid enrollees with OUD, found that patients receiving buprenorphine were 38% less likely to experience a fatal overdose in the 12 months following treatment initiation.
The medication doesn’t override your choices or your willpower. What it does is correct a neurological deficit, the dysregulation of the brain’s reward and stress systems, that makes stopping without medical support physiologically dangerous for most people. Starting MAT is a medical decision, the same as starting insulin for diabetes. Maryland Medicaid removes the cost barrier so that decision doesn’t have to wait.
How Medicaid Coverage of OUD Treatment Saves Money
A Georgetown CCF analysis estimated that every dollar invested in addiction treatment returns four to seven dollars in reduced drug-related crime, criminal justice costs, and theft. A separate study published in Health Affairs found that Medicaid enrollees with OUD who received medication-assisted treatment had 28% lower total healthcare spending compared to those who received no treatment, largely driven by reductions in emergency department visits and hospitalizations.
The financial case for coverage isn’t just an abstraction. It explains why Maryland has continued to expand and protect OUD benefits even in budget-constrained years: treating OUD costs the state less than paying for its downstream consequences. For you, this means Maryland has a structural interest in keeping coverage strong. That said, managed care plans within Maryland Medicaid vary in their authorization practices. If a provider tells you Medicaid won’t cover a specific service, verify that directly with Maryland Medicaid’s member services line before accepting the answer as final.
What to Do If You Have No Coverage or Are Between Plans
A gap in insurance coverage is not a reason to delay starting treatment. Maryland Medicaid applications can be submitted and fast-tracked through Maryland Health Connection, and emergency Medicaid covers acute detox services even before a standard eligibility determination is complete. SAMHSA’s 2022 Treatment Episode Data Set shows that uninsured patients who begin treatment through sliding-scale arrangements while applications process have significantly better retention rates than those who wait for coverage to finalize before starting.
Many providers in Maryland, including those operating without requiring insurance upfront, can begin services concurrently with your application. Ask specifically: can we start the intake process while my Medicaid application is pending? Most programs that serve Medicaid populations have workflows for exactly this situation. The answer is usually yes.
How to Use Your Maryland Medicaid Coverage to Start Treatment This Week
Start by confirming your Medicaid enrollment status. Log into your Maryland Health Connection account or call the member services number on the back of your Medicaid card. If you’re not yet enrolled, an application takes about 15 minutes and eligibility decisions are often returned within days.
Next, find a Maryland-based provider that accepts Medicaid and offers medication-assisted treatment. SAMHSA’s treatment locator at findtreatment.gov lets you filter by insurance type and medication availability. Maryland’s Behavioral Health Administration also maintains a provider directory through its website. Look for programs that verify your benefits before your first appointment, confirm pharmacy pickup logistics, and can get you in quickly. A same-week appointment at a clinic with no waitlist is a reasonable expectation, not a luxury, when you’re ready to start.
When you call, ask three questions: Do you accept Maryland Medicaid? Do you offer medication-assisted treatment including buprenorphine or methadone? What is your next available intake appointment? Those three answers tell you everything you need to know to walk through the door.
MD M.A.T.T. accepts Maryland Medicaid along with all major insurance plans and works with patients who have no coverage at all. The intake team verifies your benefits before your first visit, so you know exactly where you stand before you arrive. Appointments are available same-day and next-day with no waitlist, and transportation can be arranged through your insurance if getting there is a barrier. The goal is to remove every friction point between the moment you decide to start and the moment you actually do. Call today and ask those three questions.